. 2021 Aug 2;3(3):96–102. doi: 10.2991/chi.k.210718.001

Table 3.

Levels of high sensitivity troponin T (hsTropT) and N-terminal pro-B natriuretic peptide (NTproBNP) among 40 patients who underwent chimeric antigen receptor (CAR) T cell therapy. _a b _c represent the lower quartile a, the median b, and the upper quartile c. (A and B) Levels of hsTropT and NTproBNP at baseline (BL), day 1, days 7 and 21. (C and D) Levels of hsTropT and NTproBNP stratified by whether patients experienced grade 2 cytokine release syndrome or not (E) Levels of hsTropT stratified by whether it was abnormal (>14 ng/L) at baseline or not. (F) Levels of NTproBNP stratified by whether it was abnormal (>125 pg/mL) at baseline or not

hsTropT levels: Overall			NTproBNP levels: Overall

Day	Full group (n = 40)		Day	Full group (n = 40)

BL	_9.212.1_20.1		BL	_116.0179.1_324.8
1	_9.613.1_24.2		1	_97.8357.2_813.4
7	_9.611.9_18.0		7	_238.6420.0_1241.5
21	_10.815.3_20.2		21	_79.7176.8_278.4

hsTropT levels: by grade 2 CRS vs. not			NTproBNP levels: by grade 2 CRS vs. not

Day	No CRS (n = 22)	Yes CRS (n = 18)	Day	No CRS (n = 22)	Yes CRS (n = 18)

BL	_8.913.1_21.3	_9.211.3_18.0	BL	_136.4213.9_427.6	_91.5178.9_291.3
1	_9.912.6_25.0	_9.513.5_19.6	1	_169.6368.2_710.8	_78.0344.4_1293.5
7	_10.513.0_17.6	_9.311.4_19.1	7	_166.0373.6_711.5	_393.7949.3_1381.8
21	_10.215.3_20.8	_11.315.3_19.2	21	_77.5146.4_212.7	_150.9206.6_334.5

hsTropT levels: by abnormal vs. normal baseline hsTropT			NTproBNP levels: by abnormal vs. normal baseline NTproBNP

Day	Normal baseline hsTropT (n = 20)	Abnormal baseline hsTropT (n = 17)	Day	Normal baseline hsTropT (n = 20)	Abnormal baseline hsTropT (n = 17)

BL	_7.39.3_10.2	_16.721.0_25.2	BL	_48.184.5_102.1	_179.0276.4_485.1
1	_8.710.0_11.5	_16.425.0_32.7	1	_55.274.8_113.8	_322.9679.0_1340.0
7	_8.810.4_11.6	_13.817.8_24.0	7	_109.6260.7_410.8	_383.9949.2_2164.0
21	_9.110.8_13.6	_16.920.8_23.6	21	_52.1120.3_158.2	_138.1210.9_424.6